Poornima Ramadasand David B Duggan Author
Subjects of specialization
Affiliation
cancer, cancer oncology, Carcinogenesis
LSU Health Sciences Center, 1501 Kings Hwy, Shreveport, Louisiana, USA
Dr. Poornima Ramadas is working as scientist and professor at LSU Health Sciences Center, 1501 Kings Hwy, Shreveport, Louisiana, USA. The author has specalization in cancer, cancer oncology, chemotherapy, Carcinogenesis, Chemotherapy
Case Report Open Access
Author(s): Poornima Ramadas and David B Duggan
Treatment of Acute Myeloid Leukemia in older adults becomes challenging due to co-morbidities, poor functional status, higher incidence of unfavorable cytogenetics, and increased treatment resistance. Even though the overall survival in older patients with AML has historically remained poor, recent advances in treatment have resulted in improved survival in this population. Venetoclax, an oral BCL-2 inhibitor in combination with hypomethylating agents or low-dose cytarabine has been granted FDA approval for treatment of AML in patients who are 75 years or older or have co-morbid conditions that prohibit the use of intensive chemotherapy. This case report describes an elderly male patient who was diagnosed with AML and went into complete remission with a single dose of Venetoclax. Older ... view moreĀ»